Table 3.

Criteria and weights used in MCDA for AMC and AMR indicators in humans

AMC criteria	Weights
Estimated proportion of resistance to this antimicrobial/group of antimicrobials in infections by relevant pathogens in the population over the next 5 years	0.44	Very low Low Medium High	< 1% 1–10% 10–99% > 99%
Estimated impact of resistance to this antimicrobial/group of antimicrobials of relevant human pathogens on the affected population over the next 5 years (morbidity, mortality)	0.39	Very low Low Medium High	< 1% 1–10% 10–99% > 99%
Perceived or known percentage of prescriptions with misuse/overuse of this antimicrobial/group of antimicrobials (consumption reflects misuse/overuse and thus amenable to interventions)	0.17	Very low Low Medium High	< 1% 1–10% 10–99% > 99%

AMR criteria	Weights
Estimated incidence of infections by this resistant microorganism in the relevant population (hospital, community or total) over the next 5 years	0.42	Very low Low Medium High	< 1 per 100,000 population* 1–100 per 100,000 population* 100–1,000 per 100,000 population* > 1,000 per 100,000 population*
Estimated impact of infections by this resistant microorganism in the relevant population (hospital, community or total) over the next 5 years (morbidity, mortality)	0.37	Very low Low Medium High	< 1% 1–10% 10–99% > 99%
Perceived or known percentage of resistance of this microorganism linked to human‐to‐human transmission (reflects infection control practice and thus amenable to interventions)	0.21	Very low Low Medium High	< 1% 1–10% 10–99% > 99%

Population*: refers to inhabitants or admissions, respectively, for the community and hospital populations.